This relationship is observed across the AD continuum, including the asymptomatic phase in sporadic and genetic forms of AD. Yet certain p-tau species, but not all, are also associated with neurofibrillary tangle pathology, the secondary AD pathological hallmark. Thus, p-tau is regarded as the primary blood biomarker for AD pathology throughout all stages of the disease. Here, MAPT is linked to Alzheimer disease.